{"SLR NAME":"Perioperative mortality and morbidity in hip fractures among COVID positive and COVID negative patients: a systematic review and meta analysis","References":[{"title1":"Increased Mortality and Major Complications in Hip Fracture Care During the COVID-19 Pandemic: A New York City Perspective","References":[{"title2":"Epidemiology and social costs of hip fracture","References":[]},{"title2":"Incidence and mortality of hip fractures in the United States","References":[{"title3":"Cost-equivalence of different osteoporotic fractures"},{"title3":"Time trends and demography of mortality after fractured neck of femur in an English population, 1968-98: database study"},{"title3":"Mortality after admission to hospital with fractured neck of femur: database study"},{"title3":"Hip fracture outcomes: quality of life and functional status in older adults living in the community"},{"title3":"Deterioration in quality of life following hip fracture: a prospective study"},{"title3":"Functional outcome and quality of life following hip fracture in elderly women: a prospective controlled study"},{"title3":"The crippling consequences of fractures and their impact on quality of life"},{"title3":"Increased mortality in patients with a hip fracture:effect of pre-morbid conditions and post-fracture complications"},{"title3":"Excess mortality attributable to hip fracture in white women aged 70 years and older"},{"title3":"Effect of hip fracture on mortality in elderly women: the EPIDOS prospective study"},{"title3":"Risk of mortality following clinical fractures"},{"title3":"Survival after hip fracture: short- and long-term excess mortality according to age and gender"},{"title3":"The effect of hip fracture on mortality, hospitalization, and functional status: a prospective study"},{"title3":"The components of excess mortality after hip fracture"},{"title3":"An estimate of the worldwide prevalence, mortality and disability associated with hip fracture"},{"title3":"Mortality risk after hip fracture"},{"title3":"Hip fracture"},{"title3":"Therapies for treatment of osteoporosis in US women: cost-effectiveness and budget impact considerations"},{"title3":"Methodology for estimating current and future burden of osteoporosis in state populations: application to Florida in 2000 through 2025"},{"title3":"Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025"},{"title3":"Population trends in BMD testing, treatment, and hip and wrist fracture rates: are the hip fracture projections wrong?"},{"title3":"Secular trends in hip fracture incidence and recurrence"},{"title3":"Increasing hip fracture incidence in California Hispanics, 1983 to 2000"},{"title3":"Temporal and geographic variation in hip fracture rates for people aged 65 or older, New York State, 1985-1996"},{"title3":"Trends in hospital care for hip fractures"},{"title3":"Incidence of hip fracture over a 10-year period (1991-2000): reversal of a secular trend"},{"title3":"Incidence of hip and other osteoporotic fractures in elderly men and women: Dubbo Osteoporosis Epidemiology Study"},{"title3":"Epidemiology of fractures in England and Wales"},{"title3":"Changes in hip fracture epidemiology: redistribution between ages, genders and fracture types"},{"title3":"Rising incidence of fracture of the proximal femur"},{"title3":"Hip fractures in Finland between 1970 and 1997 and predictions for the future"},{"title3":"Increased incidence of hip fractures: a population based-study in Finland"},{"title3":"Hip fractures in the elderly: a world-wide projection"},{"title3":"Fractures in the elderly: epidemiology and demography"},{"title3":"A model of osteoporosis impact in Switzerland 2000-2020"},{"title3":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation"},{"title3":"Development of a comorbidity index using physician claims data"},{"title3":"Comorbidity risk-adjustment strategies are comparable among persons with hip fracture"},{"title3":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data"},{"title3":"Confidence intervals for directly standardized rates: a method based on the gamma distribution"},{"title3":"National trends in osteoporosis visits and osteoporosis treatment, 1988-2003"},{"title3":"Effect of risedronate on the risk of hip fracture in elderly women"},{"title3":"Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin-D-replete elderly patients"},{"title3":"Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture: a randomized, double-blind, placebo-controlled trial"},{"title3":"Guidelines for the prevention of falls in people over 65"},{"title3":"Trends in hip fracture rates in Canada"},{"title3":"Incidence and outcome of osteoporotic fractures in 2004 in Sado City, Niigata Prefecture, Japan"},{"title3":"Early mortality after hip fracture: is delay before surgery important?"},{"title3":"Replacement arthroplasty versus internal fixation for extracapsular hip fractures in adults [update of: Cochrane Database Syst Rev. 2000;(2):CD00086]"},{"title3":"Arthroplasties (with and without bone cement) for proximal femoral fractures in adults [update of: Cochrane Database Syst Rev. 2001;(3):CD001706]"},{"title3":"Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults [update of: Cochrane Database Syst Rev. 2000;(2):CD00093]"},{"title3":"Mobilisation strategies after hip fracture surgery in adults [update of: Cochrane Database Syst Rev. 2000;(3):CD001704]"},{"title3":"Hip fracture mortality: relation to age, treatment, preoperative illness, time of surgery, and complications"},{"title3":"Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women"},{"title3":"Perioperative care of the geriatric patient with diabetes or hyperglycemia"},{"title3":"Contemporary issues in the care of patients with chronic obstructive pulmonary disease"},{"title3":"Use of medications and poly-pharmacy are increasing among the elderly"}]},{"title2":"Epidemiology and outcomes of osteoporotic fractures","References":[]},{"title2":"Hip fractures:treatment and functional outcome. The development over 25 years","References":[]},{"title2":"Clinical characteristics of covid-19 in New York city","References":[{"title3":"COVID-19 Map"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Extrapulmonary manifestations of COVID-19"},{"title3":"Aki in hospitalized patients with and without COVID-19: a comparison study"},{"title3":"Aki in hospitalized patients with COVID-19"},{"title3":"Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection"},{"title3":"Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19"},{"title3":"Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction"},{"title3":"Coagulopathy and antiphospholipid antibodies in patients with Covid-19"},{"title3":"Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2"},{"title3":"Thrombosis in hospitalized patients with COVID-19 in a new York City health system"},{"title3":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy"},{"title3":"States reporting cases of COVID-19 to CDC"},{"title3":"Defining the Epidemiology of Covid-19 - Studies Needed"},{"title3":"R: a language and environment for statistical computing. R found STAT comput Vienna, Austria; R foundation for statistical computing"},{"title3":"Epidemiology of Covid-19 in a long-term care facility in King County, Washington"},{"title3":"SARS-CoV-2 infection among travelers returning from Wuhan, China"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Estimates of the severity of coronavirus disease 2019: a model-based analysis"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Covid-19 in critically Ill patients in the seattle region - case series"},{"title3":"Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]"},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state"},{"title3":"Lactate dehydrogenase, a risk factor of severe COVID-19 patients"},{"title3":"Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis"},{"title3":"Clinical characteristics of Covid-19 in New York City"},{"title3":"The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application"}]},{"title2":"Guidelines for ambulatory surgery centers for the care of surgically necessary/time-sensitive orthopaedic cases during the COVID-19 pandemic","References":[{"title3":"Fair allocation of scarce medical resources in the time of COVID-19"},{"title3":"Interim guidance for healthcare facilities: preparing for community transmission of COVID-19 in the United States"},{"title3":"Critical supply shortages - the need for ventilators and personal protective equipment during the COVID-19 pandemic"}]},{"title2":"Peri-operative considerations in urgent surgical care of suspected and confirmed COVID-19 orthopedic patients: operating rooms protocols and recommendations in the current COVID-19 pandemic","References":[]},{"title2":"Predicting discharge location among low-energy hip fracture patients using the score for trauma triage in the geriatric and middle-aged (STTGMA)","References":[{"title3":"An Aging Nation: The Older Population in the United States: Population Estimates and Projections"},{"title3":"An AOA critical issue. Geriatric trauma: young ideas"},{"title3":"In harms way: Moving the older trauma patient toward a better outcome"},{"title3":"Epidemiology of fragility fractures"},{"title3":"Geriatric hip fracture management: keys to providing a successful program"},{"title3":"Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation"},{"title3":"Effects of interventions on trajectories of health-related quality of life among older patients with hip fracture: a prospective randomized controlled trial"},{"title3":"The influence of inpatient comprehensive geriatric care on elderly patients with hip fractures: a meta-analysis of randomized controlled trials"},{"title3":"Mortality after hip fracture in the elderly: The role of a multidisciplinary approach and time to surgery in a retrospective observational study on 23,973 patients"},{"title3":"Physicians With Defined Clear Care Pathways Have Better Discharge Disposition and Lower Cost"},{"title3":"The eastbourne trauma assisted discharge scheme (TADS) reduces length of stay in hip fracture patients"},{"title3":"Factors affecting the discharge destination of hip fracture patients who live alone and have been admitted to an inpatient rehabilitation unit"},{"title3":"Risk factors for discharge to rehabilitation among hip fracture patients"},{"title3":"Development of a Middle-Aged and Geriatric Trauma Mortality Risk Score"},{"title3":"How Does Frailty Factor Into Mortality Risk Assessment of a Middle-Aged and Geriatric Trauma Population?"},{"title3":"Assessment of Patient Outcomes of rehabilitative care provided in inpatient rehabilitation facilities and after discharge"},{"title3":"Hip Arthroplasty for Fracture vs Elective Care: One Bundle Does Not Fit All"}]},{"title2":"Development of a value-based algorithm for inpatient triage of elderly hip fracture patients","References":[]},{"title2":"The coming hip and femur fracture bundle: a new inpatient risk stratification tool for care providers","References":[{"title3":"Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995"},{"title3":"BPCI Advanced"},{"title3":"Why GE, Boeing, Lowe's and Walmart are directly buying health care for employees"},{"title3":"Bundled payments for care improvement: lessons learned in the first year"},{"title3":"Single institution early experience with the bundled payments for care improvement initiative"},{"title3":"Taking risk: early results from teaching hospitals' participation in the center for Medicare and Medicaid innovation bundled payments for care improvement initiative"},{"title3":"Improvement in total joint replacement quality metrics: year one versus year three of the bundled payments for care improvement initiative"},{"title3":"Patient variables which may predict length of stay and hospital costs in elderly patients with hip fracture"},{"title3":"Relationship between the Charlson Comorbidity Index and cost of treating hip fracture: implications for bundled payment"},{"title3":"Impact of comorbidities on hospitalization costs following hip fracture"},{"title3":"Development of a middle-age and geriatric trauma mortality risk score: a tool to guide palliative care consultations"},{"title3":"How does frailty factor into mortality risk-assessment of a middle-aged and geriatric trauma population?"},{"title3":"Hip fracture programs: are they effective?"},{"title3":"The value of an organized fracture program for the elderly: early results"},{"title3":"Cost savings associated with US hospital palliative care consultation programs"},{"title3":"Factors affecting delay to surgery and length of stay for patients with hip fracture"},{"title3":"Predictors of length of hospital stay in elderly hip fracture patients"},{"title3":"Does fracture care make money for the hospital? An analysis of hospital revenues and costs for treatment of common fractures"},{"title3":"Patient factors associated with increased acute care costs of hip fractures: a detailed analysis of 402 patients"},{"title3":"Surgeon choices, and the choice of surgeons, affect total hospital charges for single-level anterior cervical surgery"},{"title3":"Variability in costs associated with total hip and knee replacement implants"},{"title3":"Can the use of an evidence-based algorithm for the treatment of intertrochanteric fractures of the hip maintain quality at a reduced cost?"}]},{"title2":"The World Health Organization's action plan on the road traffic injury pandemic: is there any action for orthopaedic trauma surgeons?","References":[]},{"title2":"Survey of COVID-19 disease among orthopaedic surgeons in Wuhan, People's Republic of China","References":[{"title3":"China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"WHO Scientific and Technical Advisory Group for Infectious Hazards. COVID-19: what is next for public health?"},{"title3":"Presumed asymptomatic carrier transmission of COVID-19"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Global surveillance for human infection with coronavirus disease (COVID-19) interim guidance"},{"title3":"of the People's Republic of China. Announcement by the National Health Commission, PRC (No. 1, 2020)"},{"title3":"Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)"},{"title3":"Priorities for the US health community responding to COVID-19"}]},{"title2":"Essential care of critical illness must not be forgotten in the COVID-19 pandemic","References":[{"title3":"Critical care and the global burden of critical illness in adults"},{"title3":"White paper on early critical care services in low resource settings"},{"title3":"Unmet need of essential treatments for critical illness in Malawi 1"},{"title3":"Dart PJ, Kinnear J, Bould MD, Mwansa SL, Rakhda Z, Snell D. 2017 An evaluation of inpatient morbidity and critical care provision in Zambia. Anaesthesia. 2017;72(2):172-80. 10.1111/anae.13709."},{"title3":"Measuring oxygen access: lessons from health facility assessments in Lagos"},{"title3":"Baker T, Schell CO, Lugazia E, Blixt J, Mulungu M, Castegren M, et al. 2015 Vital signs directed therapy: improving care in an intensive care unit in a low-income country. PLoS One. 2015; 10(12): e0144801"},{"title3":"Critical care capacity during the COVID-19 pandemic: global availability of intensive care beds"},{"title3":"A survey on critical care resources and practices in low- and middle-income countries"},{"title3":"Current challenges in the management of sepsis in ICUs in resource-poor settings and suggestions for the future"},{"title3":"Emergency and critical care services in Tanzania: a survey of ten hospitals"},{"title3":"Critical care in Malawi: the ethics of beneficence and justice"},{"title3":"Essential emergency and critical care: a consensus among global clinical experts The EECC Collaborators"},{"title3":"The global need for essential emergency and critical care"},{"title3":"Essential care of critical illness must not be forgotten in the COVID-19 pandemic"},{"title3":"Choice of providers for treating a neglected tropical disease: an empirical analysis of kala azar in Nepal"},{"title3":"Assessing the hospital surge capacity of the Kenyan health system in the face of the COVID-19 pandemic"},{"title3":"Africa's critical care capacity before COVID-19"},{"title3":"Perioperative patient outcomes in the African surgical outcomes study: a 7-day prospective observational cohort study"},{"title3":"Cost-Effectiveness Studies in the ICU"},{"title3":"Towards definitions of critical illness and critical care using concept analysis"},{"title3":"Kazibwe J, Shah HA, Kuwawenaruwa A, Schell CO, Khalid K, Tran PB, et al. 2021 Resource Use, Availability and Cost in the Provision of Critical Care in Tanzania: A Systematic Review. https://www.researchsquare.com. Accessed 25 Nov 2021"},{"title3":"Examining unit costs for COVID-19 case management in Kenya"},{"title3":"World Bank. 2022 The World Bank Databank. 2022 https://data.worldbank.org/indicator/SP.POP.TOTL?locations=KE-TZ. Accessed 3 Jan 2023"},{"title3":"Resource use, availability and cost in the provision of critical care in Tanzania: a systematic review"},{"title3":"Sawe HR, Mfinanga JA, Lidenge SJ, Mpondo BC, Msangi S, Lugazia E, et al. 2014 Disease patterns and clinical outcomes of patients admitted in intensive care units of tertiary referral hospitals of Tanzania. http://www.tanzania.go.tz. Accessed 30 Mar 2021"},{"title3":"A baseline review of the ability of hospitals in Kenya to provide emergency and critical care services for COVID-19 patients"},{"title3":"United Republic of Tanzania Ministry of Health, Community Development, Gender, Elderly and Children Health Sector Strategic Plan Leaving No One Behind. 2021"},{"title3":"Development and upgrading of public primary healthcare facilities with essential surgical services infrastructure: a strategy towards achieving universal health coverage in Tanzania"},{"title3":"The state of emergency medicine in the United Republic of Tanzania"},{"title3":"The implication of the shortage of health workforce specialist on universal health coverage in Kenya"},{"title3":"Ministry of Health Kenya. 2019 Kenya Harmonized Health Facility Assessment 2018/19. Nairobi. https://www.health.go.ke/wp-content/uploads/2020/01/KHFA-2018-19-Popular-version-report-Final-.pdf. Accessed 28 Mar 2022"},{"title3":"Edoka I, Fraser H, Jamieson L, Meyer-Rath G, Mdewa W. 2021 Inpatient Care Costs of COVID-19 in South Africa's Public Healthcare System. Int J Health Policy Manag."},{"title3":"World Health Organisation. 2021 COVID-19 Clinical management: living guidance. Geneva"},{"title3":"Towards definitions of critical illness and critical care using concept analysis"},{"title3":"The international decision support initiative reference case for economic evaluation: an aid to thought"},{"title3":"Bank of Tanzania. 2020 Bank of Tanzania Annual Report [Internet]. Dar-es-Salaam. https://www.bot.go.tz/Publications/Filter/34. Accessed 2021 Nov 19"},{"title3":"Government of Kenya. 2022 Central Bank of Kenya. https://www.centralbank.go.ke/rates/forex-exchange-rates/."},{"title3":"Kimotho J. 2020 Drug Index.it Eastern Africa. 17th Ed. Nairobi: Pharmaceutical Loci Publishers. https://textbookcentre.com/catalogue/drug-indexit-eastern-africa-17th-edition_12342/. Accessed 2022 Feb 24"},{"title3":"Ministry of Health and Social Welfare. Tanzania Service Availability and Readiness Assessment (SARA). Dar-es-Salaam: Ifakara Health Institute. 2013. https://core.ac.uk/download/pdf/19726052.pdf"},{"title3":"Rees EM, Nightingale ES, Jafari Y, Waterlow N, Clifford S, Group CW, et al. COVID-19 length of hospital stay: a systematic review and data synthesis. medRxiv. 2020. 10.1101/2020.04.30.20084780v1"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: summary of a report of 72314 cases from the Chinese center for disease control and prevention"},{"title3":"Cost-effectiveness of intensive care for hospitalized COVID-19 patients: experience from South Africa"},{"title3":"James C, Bura M, Ensor T. 2013 THE COSTS OF DELIVERING HEALTH SERVICES IN TANZANIA Findings from a comprehensive costing analysis. Ministry of Health, Government of Tanzania"},{"title3":"COVID 19 and the oxygen bottleneck. Bull World Health Organ. 2020;98(9):586-87. 10.2471/BLT.20.020920. PMID: 33012857; PMCID: PMC7463186."},{"title3":"Hospital length of stay for COVID-19 patients: Data-driven methods for forward planning"},{"title3":"Stark choices: exploring health sector costs of policy responses to COVID-19 in low-income and middle-income countries"}]},{"title2":"Excess mortality following hip fracture: a systematic epidemiological review","References":[]},{"title2":"Mortality after osteoporotic hip fracture: incidence, trends, and associated factors","References":[{"title3":"How many people develop fractures with what outcome?"},{"title3":"Mortality and institutionalization following hip fracture"},{"title3":"Early interdisciplinary hospital intervention for elderly patients with hip fractures: functional outcome and mortality"},{"title3":"Mortality after all major types of osteoporotic fracture in men and women: an observational study"},{"title3":"Mortality following fractures in older women. The study of osteoporotic fractures"},{"title3":"Epidemiology and outcomes of osteoporotic fractures"},{"title3":"The components of excess mortality after hip fracture"},{"title3":"Excess mortality following hip fracture: a systematic epidemiological review"},{"title3":"Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival"},{"title3":"Meta-analysis: excess mortality after hip fracture among older women and men"},{"title3":"Mortality following the first hip fracture in Norwegian women and men (1999-2008). A NOREPOS study"},{"title3":"Preoperative predictors for mortality following hip fracture surgery: a systematic review and meta-analysis"},{"title3":"Does the association of comorbidity with 1-year mortality after hip fracture differ according to gender? The Norwegian Epidemiologic Osteoporosis Studies (NOREPOS)"},{"title3":"Trend in hip fracture incidence and mortality in Korea: a prospective cohort study from 2002 to 2011"},{"title3":"Predictors of long-term mortality in older people with hip fracture"},{"title3":"Menendez-Colino R, Alarcon T, Gotor P, Queipo R, Ramirez-Martin R, Otero A, et al. Baseline and pre-operative 1-year mortality risk factors in a cohort of 509 hip fracture patients consecutively admitted to a co-managed orthogeriatric unit (FONDA Cohort). Injury. 2018."},{"title3":"Incidence rates of and mortality after hip fracture among German nursing home residents"},{"title3":"Associations between hospital-based rehabilitation for hip fracture and two-year outcomes for mortality and independent living: an Australian database study of 1724 elderly community-dwelling patients"},{"title3":"Mazzucchelli R, Perez-Fernandez E, Crespi N, Garcia-Vadillo A, Rodriguez Caravaca G, Gil de Miguel A, et al. Second hip fracture: incidence, trends, and predictors. Calcif Tissue Int. 2017."},{"title3":"Incidence and mortality following hip fracture in Korea"},{"title3":"Has mortality after a hip fracture increased?"},{"title3":"Mortality risk associated with low-trauma Osteoporotic fracture and subsequent fracture in men and women"},{"title3":"Risk of subsequent fracture and mortality within a period of 5 years after a non-vertebral fracture"},{"title3":"Fracture risk following an osteoporotic fracture"},{"title3":"Fractures as predictors of excess mortality in the aged - a population-based study with a 12-year followup"},{"title3":"Long-term mortality following fractures at different skeletal sites: a population-based cohort study"},{"title3":"Increased mortality after upper extremity fracture requiring inpatient care"},{"title3":"Individuals who sustain nonosteoporotic fractures continue to also sustain fragility fractures"},{"title3":"Declining incidence trends for hip fractures have not been accompanied by improvements in lifetime risk or post-fracture survival--a nationwide study of the Swedish population aged 60 years and older"},{"title3":"Trends in hip fracture incidence and mortality in Chinese population from Hong Kong 2001-09"},{"title3":"Incidence and mortality of hip fractures in the United States"},{"title3":"Secular reduction of excess mortality in hip fracture patients &gt;85 years"},{"title3":"Demographic factors in hip fracture incidence and mortality rates in California, 2000-2011"},{"title3":"Trends in hip fracture rates in Canada"},{"title3":"Trends in hip fracture-related mortality in Texas, 1990-2007"},{"title3":"European regional differences in all-cause mortality and length of stay for patients with hip fracture"},{"title3":"Trends in osteoporotic hip fracture epidemiology over a 17-year period in a Spanish population: Alcorcon 1999-2015"},{"title3":"Survival after hip fracture: short- and long-term excess mortality according to age and gender"},{"title3":"Mortality after osteoporotic fractures"},{"title3":"Excess mortality or institutionalization after hip fracture: men are at greater risk than women"}]},{"title2":"Epidemiology, treatment and mortality of trochanteric and subtrochanteric hip fractures: data from the Swedish fracture register","References":[{"title3":"Hip fractures in the elderly: a world-wide projection"},{"title3":"Geographic trends in incidence of hip fractures: a comprehensive literature review"},{"title3":"World-wide projections for hip fracture"},{"title3":"Hip fractures in adults"},{"title3":"Gender differences in patients with hip fracture: a greater risk of morbidity and mortality in men"},{"title3":"Survey of hip fractures in Japan: recent trends in prevalence and treatment"},{"title3":"Impact of age on postoperative complication rates among elderly patients with hip fracture: a retrospective matched study"},{"title3":"Nail or plate fixation of intertrochanteric hip fractures: changing pattern of practice. A review of the American Board of Orthopaedic Surgery Database"},{"title3":"Sliding hip screw versus IM nail in reverse oblique trochanteric and subtrochanteric fractures. A study of 2716 patients in the Norwegian hip fracture register"},{"title3":"Early and ultra-early surgery in hip fracture patients improves survival"},{"title3":"The effect of early surgery after hip fracture on 1-year mortality"},{"title3":"Achieving hip fracture surgery within 36 hours: an investigation of risk factors to surgical delay and recommendations for practice"},{"title3":"Early surgery within 2 days for hip fracture is not reliable as healthcare quality indicator"},{"title3":"Epidemiology and patho-anatomical pattern of 2,011 humeral fractures: data from the Swedish fracture register"},{"title3":"Clavicle fractures: epidemiology, classification and treatment of 2 422 fractures in the Swedish fracture register; an observational study"},{"title3":"Geriatric trauma hip fractures: is there a difference in outcomes based on fracture patterns?"},{"title3":"Risk factors for trochanteric and femoral neck fracture"},{"title3":"Mortality and cardiorespiratory complications in trochanteric femoral fractures: a ten year retrospective analysis"},{"title3":"Influence of fracture stability on early patient mortality and reoperation after Pertrochanteric and intertrochanteric hip fractures"},{"title3":"Use of the Gamma3 nail in a teaching hospital for trochanteric fractures: mechanical complications, functional outcomes, and quality of life"},{"title3":"Secular trend in the incidence of hip fracture in Catalonia, Spain, 2003-2014"},{"title3":"Incidence and seasonal variation in hip fracture incidence among elderly women in Norway. The HUNT study"},{"title3":"What is the underlying mechanism for the failure mode observed in the proximal femoral locking compression plate? A biomechanical study"},{"title3":"Is the best plate a nail? A review of 3230 unstable intertrochanteric fractures of the proximal femur"},{"title3":"Intramedullary nails versus sliding hip screws for AO/OTA 31-A2 trochanteric fractures in adults: a meta-analysis"},{"title3":"Do intramedullary implants improve survival in elderly patients with trochanteric fractures? A retrospective study"},{"title3":"Lateral femoral wall thickness. A reliable predictor of post-operative lateral wall fracture in intertrochanteric fractures"},{"title3":"Proximal femoral fractures: principles of management and review of literature"},{"title3":"Intertrochanteric fractures: ten tips to improve results"},{"title3":"Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults"},{"title3":"Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival"},{"title3":"Meta-analysis: excess mortality after hip fracture among older women and men"},{"title3":"Timing matters in hip fracture surgery: patients operated within 48 hours have better outcomes. A meta-analysis and meta-regression of over 190,000 patients"},{"title3":"Delay to surgery prolongs hospital stay in patients with fractures of the proximal femur"},{"title3":"Lizaur-Utrilla A, Gonzalez-Navarro B, Vizcaya-Moreno MF, Miralles Munoz FA, Gonzalez-Parreno S, Lopez-Prats FA. Reasons for delaying surgery following hip fractures and its impact on one year mortality. Int Orthop. 2018."},{"title3":"Hip fracture surgery: does time of the day matter? A case-controlled study"},{"title3":"Surgical time of day does not affect outcome following hip fracture fixation"},{"title3":"High reliability in classification of tibia fractures in the Swedish fracture register"},{"title3":"Evaluating non-responders of a survey in the Swedish fracture register: no indication of different functional result"},{"title3":"Validity of humerus fracture classification in the Swedish fracture register"}]},{"title2":"Risk factors and trends associated with mortality among adults with hip fracture in Singapore","References":[]},{"title2":"Postoperative mortality after a hip fracture over a 15-year period in Denmark: a national register study","References":[{"title3":"Mortality and life expectancy after hip fractures"},{"title3":"Changing trends in the mortality rate at 1-year post hip fracture-a systematic review"},{"title3":"Postoperative mortality after a hip fracture over a 15-year period in Denmark: a national register study"},{"title3":"Complications and patient-reported outcome after hip fracture: a consecutive annual cohort study of 664 patients"},{"title3":"More hip complications after total hip arthroplasty than after hemiarthroplasty as hip fracture treatment: analysis of 5,815 matched pairs in the Swedish Hip Arthroplasty Register"},{"title3":"Mortality and cause of death in hip fracture patients aged 65 or older: a population-based study"},{"title3":"Primary arthroplasty is better than internal fixation of displaced femoral neck fractures: a meta-analysis of 14 randomized studies with 2,289 patients"},{"title3":"General vs. neuraxial anaesthesia in hip fracture patients: a systematic review and meta-analysis"}]},{"title2":"Analysis of mortality after hip fracture on patient, hospital, and regional level in Germany","References":[]},{"title2":"COVID-19 outbreak and surgical practice: unexpected fatality in perioperative period","References":[]},{"title2":"Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection","References":[{"title3":"Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection"}]},{"title2":"The trinity of COVID-19: immunity, inflammation and intervention","References":[{"title3":"World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. WHOhttps://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (2020)."},{"title3":"Coronaviruses: an overview of their replication and pathogenesis"},{"title3":"The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"The proximal origin of SARS-CoV-2"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures"},{"title3":"The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application"},{"title3":"Early transmission dynamics in Wuhan, China, of Novel Coronavirus-infected pneumonia"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical and immunological features of severe and moderate coronavirus disease 2019"},{"title3":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"Viral load of SARS-CoV-2 in clinical samples"},{"title3":"Viral load kinetics of SARS-CoV-2 infection in first two patients in Korea"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"Zhang, B. et al. Clinical characteristics of 82 death cases with COVID-19. Preprint at medRxiv10.1101/2020.02.26.20028191 (2020)."},{"title3":"Acute renal impairment in coronavirus-associated severe acute respiratory syndrome"},{"title3":"ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Zhao, Y. et al. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. Preprint at bioRxiv10.1101/2020.01.26.919985 (2020)."},{"title3":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 in lung diseases"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"},{"title3":"Sex hormones determine immune response"},{"title3":"The SARS-CoV S glycoprotein: expression and functional characterization"},{"title3":"Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor"},{"title3":"A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2"},{"title3":"Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry"},{"title3":"Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides"},{"title3":"Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors"},{"title3":"Structure analysis of the receptor binding of 2019-nCoV"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease"},{"title3":"Chinese Clinical Trial Register. Chictr.org.cnhttp://www.chictr.org.cn/showprojen.aspx?proj=49088 (2020)."},{"title3":"Pipeline Review. APEIRON's respiratory drug product to start pilot clinical trial to treat coronavirus disease COVID-19 in China. Pipeline Reviewhttps://pipelinereview.com/index.php/2020022673884/Proteins-and-Peptides/APEIRONs-respiratory-drug-product-to-start-pilot-clinical-trial-to-treat-coronavirus-disease-COVID-19-in-China.html (2020)."},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"Identification of nafamostat as a potent inhibitor of Middle East respiratory syndrome coronavirus S protein-mediated membrane fusion using the split-protein-based cell-cell fusion assay"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target"},{"title3":"Virus isolation from the first patient with SARS-CoV-2 in Korea"},{"title3":"Histopathologic changes and SARS-CoV-2 immunostaining in the lung of a patient with COVID-19"},{"title3":"Severe acute respiratory syndrome coronavirus viroporin 3a activates the NLRP3 inflammasome"},{"title3":"Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells"},{"title3":"Yang, M. Cell pyroptosis, a potential pathogenic mechanism of 2019-nCoV infection. SSRN10.2139/ssrn.3527420 (2020)."},{"title3":"An interferon-gamma-related cytokine storm in SARS patients"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer"},{"title3":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Liao, M. et al. The landscape of lung bronchoalveolar immune cells in COVID-19 revealed by single-cell RNA sequencing. Preprint at medRxiv10.1101/2020.02.23.20026690 (2020)."},{"title3":"Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients"},{"title3":"Suppression of innate antiviral response by severe acute respiratory syndrome coronavirus M protein is mediated through the first transmembrane domain"},{"title3":"Group 2 coronaviruses prevent immediate early interferon induction by protection of viral RNA from host cell recognition"},{"title3":"Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling"},{"title3":"Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling"},{"title3":"Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane"},{"title3":"Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China"},{"title3":"Age-related increases in PGD2 expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice"},{"title3":"A well infant with coronavirus disease 2019 (COVID-19) with high viral load"},{"title3":"Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis"},{"title3":"SARS-coronavirus replication in human peripheral monocytes/macrophages"},{"title3":"Severe acute respiratory syndrome and the innate immune responses: modulation of effector cell function without productive infection"},{"title3":"Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells"},{"title3":"US National Library of Medicine. ClinicalTrials.govhttps://clinicaltrials.gov/ct2/show/NCT04273321 (2020)."},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Pharmacologic treatment of SARS: current knowledge and recommendations"},{"title3":"Chinese Clinical Trial Register. Chictr.org.cnhttp://www.chictr.org.cn/showproj.aspx?proj=49409 (2020)."},{"title3":"Liu, A. China turns Roche arthritis drug Actemra against COVID-19 in new treatment guidelines. FiercePharmahttps://www.fiercepharma.com/pharma-asia/china-turns-roche-arthritis-drug-actemra-against-covid-19-new-treatment-guidelines (2020)."},{"title3":"Roivant Sciences. Roivant announces development of anti-GM-CSF monoclonal antibody to prevent and treat acute respiratory distress syndrome (ARDS) in patients with COVID-19. Roivant Scienceshttps://roivant.com/roivant-announces-development-of-anti-gm-csf-monoclonal-antibody-to-prevent-and-treat-acute-respiratory-distress-syndrome-ards-in-patients-with-covid-19/ (2020)."},{"title3":"Humanigen. Humanigen partners with CTI, a leading contract research organization, for planned phase III study for lenzilumab for coronavirus treatment. Humanigenhttps://www.humanigen.com/press/Humanigen-Partners-With-CTI%2C-A-Leading-Contract-Research-Organization%2C-For-Planned-Phase-III-Study-For-Lenzilumab-For-Coronavirus-Treatment (2020)."},{"title3":"Izana Bioscience. Initiation of two-centre compassionate use study involving namilumab in the treatment of individual patients with rapidly worsening COVID-19 infection in Italy. Izana Biosciencehttps://izanabio.com/initiation- of-two-centre-compassionate-use-study-involving-namilumab-in-the-treatment-of-individual-patients-with-rapidly-worsening-covid-19-infection-in-italy/ (2020)."},{"title3":"CytoSorbents Corportation. CytoSorb, the Wuhan coronavirus, and cytokine storm.PR Newswirehttps://www.prnewswire.com/news-releases/cytosorb-the-wuhan-coronavirus-and-cytokine-storm-300994196.html (2020)."},{"title3":"Chen, C. et al. Thalidomide combined with low-dose glucocorticoid in the treatment of COVID-19 pneumonia. Preprintshttps://www.preprints.org/manuscript/202002.0395/v1 (2020)."},{"title3":"US National Library of Medicine. ClinicalTrials.govhttps://clinicaltrials.gov/ct2/show/NCT04273581 (2020)."},{"title3":"US National Library of Medicine. ClinicalTrials.govhttps://clinicaltrials.gov/ct2/show/NCT04273529 (2020)."},{"title3":"TNF-alpha inhibition for potential therapeutic modulation of SARS coronavirus infection"},{"title3":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial"},{"title3":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)"},{"title3":"Expanding horizons for clinical applications of chloroquine, hydroxychloroquine, and related structural analogues"},{"title3":"A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19"},{"title3":"Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis"},{"title3":"Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients"},{"title3":"Human CD4+ memory T-lymphocyte responses to SARS coronavirus infection"},{"title3":"Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients"},{"title3":"Understanding the T cell immune response in SARS coronavirus infection"},{"title3":"Immune responses to Middle East respiratory syndrome coronavirus during the acute and convalescent phases of human infection"},{"title3":"Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection"},{"title3":"A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice"},{"title3":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice"},{"title3":"Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants"},{"title3":"Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV"},{"title3":"A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge"},{"title3":"Developing Covid-19 vaccines at pandemic speed"},{"title3":"Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19"},{"title3":"Profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers"},{"title3":"Early detection of antibodies against various structural proteins of the SARS-associated coronavirus in SARS patients"},{"title3":"Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes"},{"title3":"CGTN. Expert: recovered coronavirus patients are still prone to reinfection. YouTubehttps://www.youtube.com/watch?v=GZ99J7mlaIQ (2020)."},{"title3":"The Straits Times. Japanese woman reinfected with coronavirus weeks after initial recovery. The Straits Timeshttps://www.straitstimes.com/asia/east-asia/japanese-woman-reinfected-with-coronavirus-weeks-after-initial-recovery (2020)."},{"title3":"NHK World-Japan. Japanese man tests positive for coronavirus again. NHKhttps://www3.nhk.or.jp/nhkworld/en/news/20200315_13/ (2020)."},{"title3":"Xinhua. China puts 245 COVID-19 patients on convalescent plasma therapy. Xinhuanethttp://www.xinhuanet.com/english/2020-02/28/c_138828177.htm (2020)."},{"title3":"Use of convalescent plasma therapy in SARS patients in Hong Kong"},{"title3":"Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients"},{"title3":"Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital"},{"title3":"Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies"},{"title3":"Wang, C. et al. A human monoclonal antibody blocking SARS-CoV-2 infection. Preprint at bioRxiv10.1101/2020.03.11.987958 (2020)."},{"title3":"Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine"},{"title3":"The keypoints in treatment of the critical coronavirus disease 2019 patient"},{"title3":"CNA. Chinese doctors 'using plasma therapy' on COVID-19 patients. CNAhttps://www.channelnewsasia.com/news/asia/chinese-doctors-using-plasma-therapy-on-covid-19-patients-12444244 (2020)."},{"title3":"3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012"},{"title3":"VIR. Press release details: Vir Biotechnology applying multiple platforms to address public health risk from Wuhan coronavirus. VIRhttps://investors.vir.bio/news-releases/news-release-details/vir-biotechnology-applying-multiple-platforms-address-public (2020)."},{"title3":"Cohen, J. Can an anti-HIV combination or other existing drugs outwit the new coronavirus? Sciencehttps://www.sciencemag.org/news/2020/01/can-anti-hiv-combination-or-other-existing-drugs-outwit-new-coronavirus (2020)."},{"title3":"Duddu, P. Coronavirus treatment: vaccines/drugs in the pipeline for COVID-19. Clinical Trials Arenahttps://www.clinicaltrialsarena.com/analysis/coronavirus-mers-cov-drugs/ (2020)."},{"title3":"Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology"},{"title3":"Antibody responses to individual proteins of SARS coronavirus and their neutralization activities"},{"title3":"GISAID. Receptor binding surveillance for high quality genomes. GISAIDhttps://www.gisaid.org/ (2020)."},{"title3":"Mutations in the spike protein of Middle East respiratory syndrome coronavirus transmitted in Korea increase resistance to antibody-mediated neutralization"},{"title3":"Escape from human monoclonal antibody neutralization affects in vitro and in vivo fitness of severe acute respiratory syndrome coronavirus"},{"title3":"Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses"},{"title3":"Neutralizing antibody response and SARS severity"},{"title3":"Is COVID-19 receiving ADE from other coronaviruses?"},{"title3":"Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection"},{"title3":"Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals"},{"title3":"Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia"},{"title3":"Transmission of MERS-coronavirus in household contacts"},{"title3":"Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea"},{"title3":"Fcgamma receptors as regulators of immune responses"},{"title3":"The role of Fc-FcgammaR interactions in IgG-mediated microbial neutralization"},{"title3":"Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation"},{"title3":"Clinical trial analysis of 2019-nCoV therapy registered in China"},{"title3":"Structural basis of receptor recognition by SARS-CoV-2"},{"title3":"Structure of Severe Acute Respiratory Syndrome Coronavirus Receptor-binding Domain Complexed with Neutralizing Antibody"}]},{"title2":"The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the Perspectives of clinical immunologists from China","References":[{"title3":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology"},{"title3":"Cytokine storm and sepsis disease pathogenesis"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP)"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal"},{"title3":"The Diagnosis and Treatment Plan for 2019-nCoV (The Seventh Trial Edition)"},{"title3":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China"},{"title3":"A pathological report of three COVID-19 cases by minimally invasive autopsies"},{"title3":"New fronts emerge in the influenza cytokine storm"},{"title3":"Cytokine release syndrome"},{"title3":"Advances in the research of cytokine storm mechanism induced by Corona virus disease 2019 and the corresponding immunotherapies"},{"title3":"The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study"},{"title3":"High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome"},{"title3":"Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong"},{"title3":"Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience"},{"title3":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016"},{"title3":"Understanding of COVID-19 based on current evidence"},{"title3":"COVID-19: an update on the epidemiological, clinical, preventive and therapeutic evidence and guidelines of integrative Chinese-Western medicine for the management of 2019 novel coronavirus disease"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"},{"title3":"Clinical Management of Severe Acute Respiratory Infection when Novel Coronavirus (nCoV) Infection is Suspected"},{"title3":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease"},{"title3":"Preventing HIV infection without targeting the virus: how reducing HIV target cells at the genital tract is a new approach to HIV prevention"},{"title3":"Hydroxychloroquine inhibits Zika virus NS2B-NS3 protease"},{"title3":"Hydroxychloroquine-inhibited dengue virus is associated with host defense machinery"},{"title3":"Chloroquine could be used for the treatment of filoviral infections and other viral infections that emerge or emerged from viruses requiring an acidic pH for infectivity"},{"title3":"Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice"},{"title3":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread"},{"title3":"Acidotropic amines inhibit proteolytic processing of flavivirus prM protein"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"Clinical trial analysis of 2019-nCoV therapy registered in China"},{"title3":"Discovering drugs to treat coronavirus disease 2019 (COVID-19)"}]},{"title2":"Tranexamic acid safely reduced blood loss in hemi- and total hip arthroplasty for acute femoral neck fracture: a randomized clinical trial","References":[]}]},{"title1":"Hip Fracture Outcomes During the COVID-19 Pandemic: Early Results From New York","References":[{"title2":"Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complications","References":[]},{"title2":"Covid-19: risk factors for severe disease and death","References":[]},{"title2":"Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals","References":[]},{"title2":"Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study","References":[]},{"title2":"Characteristics and early prognosis of COVID-19 infection in fracture patients","References":[{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Washington State 2019-nCoV Case Investigation Team. First case of 2019 novel coronavirus in the United States"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Risk of long-term infection-related death in clinical osteoporotic vertebral fractures: a hospital-based analysis"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Chinese"},{"title3":"Enhanced recovery after surgery program implementation in 2 surgical populations in an integrated health care delivery system"},{"title3":"Traumatic dislocation of the hip"},{"title3":"Accelerated surgery versus standard care in hip fracture (HIP ATTACK): an international, randomised, controlled trial"},{"title3":"Hip attack for hip fractures: is ultra-early surgery necessary?"},{"title3":"Association of overlapping surgery with increased risk for complications following hip surgery: a population-based, matched cohort study"},{"title3":"The association between dietary inflammatory properties and bone mineral density and risk of fracture in US adults"},{"title3":"Laryngoscope-assisted and cotton ball wiping methods in prevention of oral and pulmonary infection in patients receiving mechanical ventilation and the influence on hypersensitive C-reactive protein and procalcitonin"},{"title3":"Clinical characteristics and risk factors of postoperative pneumonia after hip fracture surgery: a prospective cohort study"},{"title3":"Severe acute respiratory syndrome (SARS) in a geriatric patient with a hip fracture. A case report"}]},{"title2":"Treatment of proximal femoral fragility fractures in patients with COVID-19 during the SARS-CoV-2 outbreak in Northern Italy","References":[{"title3":"Coronavirus Disease 2019 (COVID-19) in Italy"},{"title3":"Papa Giovanni XXIII Bergamo Hospital at the time of the COVID-19 outbreak: letter from the warfront"},{"title3":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies"},{"title3":"Fracture and dislocation classification compendium-2018"},{"title3":"Reliability of the classification of proximal femur fractures: Does clinical experience matter?"},{"title3":"2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological presentation"},{"title3":"Nuovo coronavirus"},{"title3":"Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis"},{"title3":"Optimization of perioperative management of proximal femoral fracture in the elderly"},{"title3":"Is anesthesia technique associated with a higher risk of mortality or complications within 90 days of surgery for geriatric patients with hip fractures?"},{"title3":"Perioperative outcomes in geriatric patients undergoing hip fracture surgery with different anesthesia techniques: A systematic review and meta-analysis"},{"title3":"Efficacy and safety of femoral nerve block for the positioning of femur fracture patients before a spinal block - A systematic review and meta-analysis"}]},{"title2":"Mortality rates of patients with proximal femoral fracture in a Worldwide pandemic","References":[{"title3":"China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"[COVID-19 situation in Spain.]"},{"title3":"Novel coronavirus COVID-19: current evidence and evolving strategies"},{"title3":"What we do when a COVID-19 patient needs an operation: operating room preparation and guidance"},{"title3":"Novel coronavirus and orthopaedic surgery: early experiences from Singapore"},{"title3":"Preparing to perform trauma and orthopaedic surgery on patients with COVID-19"},{"title3":"Secular trend in the incidence of hip fracture in Catalonia, Spain, 2003-2014"},{"title3":"Thirty-day mortality after hip fractures: has anything changed?"},{"title3":"Mortality after osteoporotic hip fracture: incidence, trends, and associated factors"},{"title3":"Epidemiology, treatment and mortality of trochanteric and subtrochanteric hip fractures: data from the Swedish Fracture Register"},{"title3":"Nonoperative geriatric hip fracture treatment is associated with increased mortality: a matched cohort study"},{"title3":"Characteristics and early prognosis of COVID-19 infection in fracture patients"},{"title3":"China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Introduction: fracture and dislocation classification compendium-2018"},{"title3":"Accelerated surgery versus standard care in hip fracture (HIP ATTACK): an international, randomised, controlled trial"}]},{"title2":"The strengthening the reporting of observational studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","References":[]},{"title2":"Detection of SARS-CoV-2 in different types of clinical specimens","References":[{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov"},{"title3":"Smoking upregulates angiotensin-converting enzyme-2 Receptor: a potential adhesion site for novel coronavirus SARS-CoV-2 (Covid-19)"},{"title3":"Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020"},{"title3":"Detection of SARS-CoV-2 in different types of clinical specimens"},{"title3":"Sputum and feces after conversion of pharyngeal samples in patients with COVID-19"},{"title3":"Clinical characteristics of imported cases of coronavirus disease 2019 (COVID-19) in Jiangsu Province: a multicenter descriptive study"},{"title3":"Preferred reporting items for systematic review and meta-analysis protocols (prisma-p) 2015: elaboration and explanation"},{"title3":"An evidence-based practice guideline for the peer review of electronic search strategies"},{"title3":"PubMed, ScienceDirect, Scopus or Google Scholar:which is the best search engine for an effective literature research in laser medicine?"},{"title3":"Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of family cluster"},{"title3":"Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau"},{"title3":"Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously Xiong"},{"title3":"Meta-Analyst: software for meta-analysis of binary, continuous, and diagnostic data"},{"title3":"Persistence of chloroquine resistance alleles in malaria endemic countries: a systematic review of burden and risk factors"},{"title3":"Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study"}]},{"title2":"A review of ASA physical status:historical perspectives and modern developments","References":[]},{"title2":"Validation of a combined comorbidity index","References":[]},{"title2":"Chest radiographic and CT findings of the 2019 novel coronavirus disease (Covid-19): analysis of nine patients treated in Korea","References":[{"title3":"A novel Coronavirus from patients with pneumonia in China, 2019"},{"title3":"Early transmission dynamics in Wuhan, China, of novel Coronavirus-infected pneumonia"},{"title3":"CT imaging features of 2019 novel Coronavirus (2019-nCoV)"},{"title3":"Emerging coronavirus 2019-nCoV pneumonia"},{"title3":"Time course of lung changes on chest CT during recovery from 2019 novel Coronavirus (COVID-19) pneumonia"},{"title3":"The first case of 2019 novel Coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures"},{"title3":"A chest radiograph scoring system in patients with severe acute respiratory infection: a validation study"},{"title3":"Fleischner Society: glossary of terms for thoracic imaging"},{"title3":"Middle East respiratory syndrome Coronavirus (MERS-CoV) infection: chest CT findings"},{"title3":"CT correlation with outcomes in 15 patients with acute Middle East respiratory syndrome coronavirus"},{"title3":"Thin-section CT of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease"},{"title3":"Middle East respiratory syndrome-Coronavirus infection: a case report of serial computed tomographic findings in a young male patient"},{"title3":"A correlation between the severity of lung lesions on radiographs and clinical findings in patients with severe acute respiratory syndrome"},{"title3":"Radiographic-clinical correlation in severe acute respiratory syndrome: study of 1373 patients in Hong Kong"},{"title3":"Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients"},{"title3":"Acute Middle East respiratory syndrome Coronavirus: temporal lung changes observed on the chest radiographs of 55 patients"},{"title3":"Novel Coronavirus pneumonia outbreak in 2019: computed tomographic findings in two cases"},{"title3":"Imaging profile of the COVID-19 infection: radiologic findings and literature review"},{"title3":"CT manifestations of two cases of 2019 novel Coronavirus (2019-nCoV) pneumonia"},{"title3":"Chest imaging appearance of COVID-19 infection"},{"title3":"The reversed halo sign: update and differential diagnosis"}]},{"title2":"Preparing to perform trauma and orthopaedic surgery on patients with COVID-19","References":[{"title3":"China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients"},{"title3":"What we do when a COVID-19 patient needs an operation: operating room preparation and guidance"},{"title3":"Coronaviruses: an overview of their replication and pathogenesis"},{"title3":"Submicron and nanoparticulate matter removal by HEPA-rated media filters and packed beds of granular materials"},{"title3":"Nanoparticle penetration through filter media and leakage through face seal interface of N95 filtering facepiece respirators"},{"title3":"Surgical helmets and SARS infection"},{"title3":"Characterization of aerosols produced during surgical procedures in hospitals"},{"title3":"Minimally invasive surgery and the novel coronavirus outbreak: lessons learned in China and Italy"},{"title3":"The Lancet. COVID-19: protecting health-care workers"}]},{"title2":"Time to surgery is associated with thirty-day and ninety-day mortality after proximal femoral fracture","References":[]},{"title2":"Mortality by timing of hip fracture surgery: factors and relationships at play","References":[]},{"title2":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","References":[]},{"title2":"COVID-19: consider cytokine storm syndromes and immunosuppression","References":[{"title3":"Coronavirus disease 2019 (COVID-19)situation report - 52"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China"},{"title3":"Adult haemophagocytic syndrome"},{"title3":"Macrophage activation-like syndrome: a distinct entity leading to early death in sepsis"},{"title3":"Pulmonary involvement in patients with hemophagocytic lymphohistiocytosis"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"},{"title3":"Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase iii trial"},{"title3":"A multicenter, randomized controlled trial for the efficacy and safety of tocilizumab in the treatment of new coronavirus pneumonia (COVID-19)"},{"title3":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease"},{"title3":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome"}]},{"title2":"Cytokine storm syndrome: looking toward the precision medicine era","References":[]},{"title2":"Inflammation, fracture, and bone repair","References":[]},{"title2":"Anti-inflammatory properties of anesthetic agents","References":[{"title3":"Anesthetics, immune cells, and immune responses"},{"title3":"Influence of anesthetic drugs on immune response: from inflammation to immunosuppression"},{"title3":"Microbial Infections, Immunomodulation, and Drugs of Abuse"},{"title3":"Effects of general anaesthesia on inflammation"},{"title3":"Stress hormones, proinflammtory and anti-inflammatory cytokines, and autoimmunity"},{"title3":"Neuroendocrine and inflammatory aspects of surgery: do they affect outcome?"},{"title3":"The influence of ether and ether anesthesia on bacteriolysis, agglutination and phagocytosis"},{"title3":"The effect of general or spinal anaesthesia on pro- and anti-inflammatory intracellular cytokines in patients undergoing appendicectomy using flow cytometric method"},{"title3":"Colucci D, Harvey G, Gayol MC, Elena G, Puig N. Halothane anesthesia in mice: effect on the phagocytic activity and respiratory burst of peritoneal macrophages. Neuroimmunomodulation. 2011;18:11-18."},{"title3":"Increased apoptosis of peripheral blood mononuclear cells (PBMC) during general and epidural anaesthesia in dogs"},{"title3":"The anti-inflammatory effects of ketamine: state of the art"},{"title3":"Ketamine inhibits transcription factors activator protein 1 and nuclear factor-kappab, Interleukin-8 production, as well as CD11b and CD16 expression: studies in human leukocytes and leukocytic cell lines"},{"title3":"Ketamine and peripheral inflammation"},{"title3":"Ketamine: new uses for an old drug?"},{"title3":"Effects of midazolam and dexmedetomidine on inflammatory responses and gastric intramucosal pH to sepsis, in critically ill patients"},{"title3":"Interaction of benzodiazepines with mouse macrophages"},{"title3":"The inhibitory effects of thiopental, midazolam, and ketamine on human neutrophil functions"},{"title3":"Midazolam inhibits proinflammatory mediators in the lipopolysaccharide-activated macrophage"},{"title3":"Thiopentone and propofol, but not methohexitone nor midazolam, inhibit neutrophil oxidative responses to the bacterial peptide FMLP"},{"title3":"Propofol decreases random and chemotactic stimulated locomotion of human neutrophils in vitro"},{"title3":"Propofol inhibits human neutrophil functions"},{"title3":"Mechanisms of intralipid effect on polymorphonuclear leukocytes"},{"title3":"Propofol emulsion reduces proliferative responses of lymphocytes from intensive care patients"},{"title3":"Modulation of endotoxin-stimulated TNF-alpha gene expression by ketamine and propofol in cultured human whole blood"},{"title3":"Editor's choice: Opioids and immune modulation: more questions than answers"},{"title3":"Opioids and the immune system"},{"title3":"Immunosuppression by morphine is mediated by central pathways"},{"title3":"Opioid mediated effects on the immune system: sympathetic nervous system involvement"},{"title3":"Detection and function of opioid receptors on cells from the immune system"},{"title3":"Opioid peptide-expressing leukocytes: identification, recruitment, and simultaneously increasing inhibition of inflammatory pain"},{"title3":"Effects of fentanyl on cellular immune functions in man"},{"title3":"Effect of the opioid remifentanil on cellular immune response in the rat"},{"title3":"Dose-dependent rate of nosocomial pulmonary infection in mechanically ventilated patients with brain oedema receiving barbiturates: a prospective case study"},{"title3":"Substances used for local and general anaesthesia in major surgery suppress proliferative responsiveness of normal rat peripheral blood mononuclear cells in culture"},{"title3":"Effects of short-term propofol and dexmedetomidine on pulmonary morphofunction and biological markers in experimental mild acute lung injury"},{"title3":"Effects of dexmedetomidine on inflammatory responses in patients undergoing laparoscopic cholecystectomy"},{"title3":"Anti-inflammatory effects of perioperative dexmedetomidine administered as an adjunct to general anesthesia: a meta-analysis"},{"title3":"Yoon-Mi L, Byeng CS, Kyung-Jin Y. Impact of volatile anesthetics on oxidative stress and inflammation. Biomed Res Int. 2015;242709."},{"title3":"Volatile anesthetics-induced neuroinflammatory and anti-inflammatory responses"},{"title3":"Anti-inflammatory properties of local anesthetics and their present and potential clinical implications"},{"title3":"Regional anaesthesia, local anaesthetics and the surgical stress response"},{"title3":"The systemic inflammatory response to anaesthesia and surgery"},{"title3":"Anesthesia drugs, immunity, and long-term outcome"},{"title3":"Perioperative immunosuppression in cancer patients"},{"title3":"Anesthetics and immune function"},{"title3":"Treatment of tetanus; severe bone-marrow depression after prolonged nitrous-oxide anaesthesia"},{"title3":"Adrenocortical suppression with etomidate"}]},{"title2":"Fascia Iliaca regional anesthesia in hip fracture patients revisited: which fractures and surgical procedures benefit most?","References":[]},{"title2":"A comparison in outcomes of preoperative single-shot versus continuous catheter fascia Iliaca regional anesthesia in Geriatric hip fracture patients","References":[]},{"title2":"Universal screening for SARS-CoV-2 in Women admitted for delivery","References":[]}]},{"title1":"Thirty-Day Mortality Rate of Patients With Hip Fractures During the COVID-19 Pandemic: A Single Centre Prospective Study in the United Kingdom","References":[{"title2":"Clinical guide for the perioperative care of people with fragility fractures during the coronavirus pandemic","References":[]},{"title2":"Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019:United States, February 12-March 28, 2020","References":[{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"Severe outcomes among patients with coronavirus disease 2019 (COVID-19):United States, February 12-March 16, 2020."},{"title3":"Heart disease and stroke statistics:2020 update: a report from the American Heart Association."},{"title3":"Urban-rural county and state differences in chronic obstructive pulmonary disease:United States, 2015."}]},{"title2":"Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection","References":[{"title3":"Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection"}]},{"title2":"Fracture and Dislocation Classification Compendium:2018","References":[]},{"title2":"Development and validation of a preoperative scoring system to predict 30 day mortality in patients undergoing hip fracture surgery","References":[]},{"title2":"A global clinical measure of fitness and frailty in elderly people","References":[]},{"title2":"Treatment of proximal femoral fragility fractures in patients with COVID-19 during the SARS-CoV-2 outbreak in Northern Italy","References":[{"title3":"Coronavirus Disease 2019 (COVID-19) in Italy"},{"title3":"Papa Giovanni XXIII Bergamo Hospital at the time of the COVID-19 outbreak: letter from the warfront"},{"title3":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies"},{"title3":"Fracture and dislocation classification compendium-2018"},{"title3":"Reliability of the classification of proximal femur fractures: Does clinical experience matter?"},{"title3":"2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological presentation"},{"title3":"Nuovo coronavirus"},{"title3":"Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis"},{"title3":"Optimization of perioperative management of proximal femoral fracture in the elderly"},{"title3":"Is anesthesia technique associated with a higher risk of mortality or complications within 90 days of surgery for geriatric patients with hip fractures?"},{"title3":"Perioperative outcomes in geriatric patients undergoing hip fracture surgery with different anesthesia techniques: A systematic review and meta-analysis"},{"title3":"Efficacy and safety of femoral nerve block for the positioning of femur fracture patients before a spinal block - A systematic review and meta-analysis"}]},{"title2":"Mortality rates of patients with proximal femoral fracture in a worldwide pandemic: preliminary results of the Spanish HIP-COVID observational study","References":[{"title3":"China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"[COVID-19 situation in Spain.]"},{"title3":"Novel coronavirus COVID-19: current evidence and evolving strategies"},{"title3":"What we do when a COVID-19 patient needs an operation: operating room preparation and guidance"},{"title3":"Novel coronavirus and orthopaedic surgery: early experiences from Singapore"},{"title3":"Preparing to perform trauma and orthopaedic surgery on patients with COVID-19"},{"title3":"Secular trend in the incidence of hip fracture in Catalonia, Spain, 2003-2014"},{"title3":"Thirty-day mortality after hip fractures: has anything changed?"},{"title3":"Mortality after osteoporotic hip fracture: incidence, trends, and associated factors"},{"title3":"Epidemiology, treatment and mortality of trochanteric and subtrochanteric hip fractures: data from the Swedish Fracture Register"},{"title3":"Nonoperative geriatric hip fracture treatment is associated with increased mortality: a matched cohort study"},{"title3":"Characteristics and early prognosis of COVID-19 infection in fracture patients"},{"title3":"China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Introduction: fracture and dislocation classification compendium-2018"},{"title3":"Accelerated surgery versus standard care in hip fracture (HIP ATTACK): an international, randomised, controlled trial"}]}]}]}